28. 全身性アミロイドーシス
[臨床試験数:212,薬物数:234(DrugBank:72),標的遺伝子数:54,標的パスウェイ数:170]
Searched query = "Systemic amyloidosis", "AL amyloidosis", "Immunoglobulin light chain amyloidosis", "Amyloid light-chain amyloidosis", "Familial amyloidosis", "Familial amyloid polyneuropathy", "Senile transthyretin amyloidosis", "Senile TTR amyloidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT00807872 (ClinicalTrials.gov) | December 2008 | 11/12/2008 | Radioimmunoimaging of AL Amyloidosis | Radioimmunoimaging (PET/CT) of Patients With AL Amyloidosis Using the 124I-Labeled Amyloid-Reactive Monoclonal Antibody Mu 11-1F4 | Primary Amyloidosis | Biological: 124I-labeled monoclonal antibody Mu 11-1F4 | University of Tennessee | FDA Office of Orphan Products Development | Completed | 21 Years | 90 Years | Both | 40 | Phase 1 | United States |
2 | NCT01409148 (ClinicalTrials.gov) | November 2008 | 28/7/2011 | Radioimmunoimaging of AL Amyloidosis | Radioimmunoimaging (PET/CT) of Patients With AL Amyloidosis Using the 124I-Labeled Amyloid-Reactive Monoclonal Antibody Mu 11-1F4 | AL Amyloidosis | Biological: 124I-labeled monoclonal antibody Mu 11-1F4 | University of Tennessee | Food and Drug Administration (FDA) | Completed | 21 Years | 90 Years | Both | 38 | Phase 1 | United States |